CVS Health (CVS) Form 4 CVS HEALTH / Thomas M Moriarty ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Moriarty Thomas M

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RI 02895

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2022		M		100,976	A	$78.05	709,105.0221	D
Common Stock	12/15/2022		S(1)		100,976	D	$98.4027	608,129.0221	D
Common Stock	12/15/2022		M		36,490	A	$62.21	644,619.0221	D
Common Stock	12/15/2022		S(2)		36,490	D	$98.2425	608,129.0221	D
Common Stock								159,120	I	By GRAT
Stock Unit								47,325.339	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$104.82							04/01/2017(5)	04/01/2023	Common Stock	71,696		71,696	D
Stock Option	$54.19							04/01/2020(6)	04/01/2029	Common Stock	50,502		50,502	D
Stock Option	$58.34(7)							04/01/2021(8)	04/01/2030	Common Stock	98,558		98,558	D
Stock Option(9)	$74.3							04/01/2022	04/01/2031	Common Stock	116,622		116,622	D
Stock Option	$101.09							04/01/2023(10)	04/01/2032	Common Stock	46,777		46,777	D
Stock Option	$78.05	12/15/2022		M			100,976	04/03/2018(3)	04/03/2024	Common Stock	100,976	$0	24,248	D
Stock Option	$62.21	12/15/2022		M			36,490	04/01/2019(4)	04/01/2025	Common Stock	36,490	$0	0	D

Explanation of Responses:

1. All sales were effected pursuant to a Rule 10b5-1 plan.

2. All sales were effected pursuant to a Rule 10b5-1 plan.

3. Option became exercisable in four equal annual installments, commencing 4/3/2018.

4. Option became exercisable in four equal annual installments, commencing 4/1/2019.

5. Option became exercisable in four equal annual installments, commencing 4/1/2017.

6. Option became exercisable in four equal annual installments, commencing 4/1/2020.

7. The number of shares subject to the option were calculated using a 30-day average price.

8. Option became exercisable in four equal annual installments, commencing 4/1/2021.

9. Option became exercisable in four equal annual installments, commencing 4/1/2022.

10. Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

	/s/ Thomas M. Moriarty	12/16/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.